Transaction · 0001628280-26-058648

Curran Terrie

Curran Terrie, DIR, reported an open-market or private sale at Arcutis Biotherapeutics, Inc. involving 1072.000000 shares for an estimated $27912.31. Reported holdings after the transaction were 23526.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
ARQTArcutis Biotherapeutics, Inc.
Filing timeAug 24
Trade dateAug 20, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$24.78
Pre-filing
1mo ago +14.0%1w ago +4.2%1d ago +6.8%
Returns since
7d +0.2%30d +0.2%90d +0.2%180d +0.2%1y +0.2%

ARQT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ARQT since 2026-08-24Filed 10 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-058648
Common Stock
Transaction date
Aug 20, 2026
Filed Aug 24, 2026, 08:19 PM · 4d delay
Shares
1.07k sh
$2.60k per share
Estimated value
-$2.79M
Computed from shares × price
Holdings after
23.5k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.

  2. F2

    The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.2228, inclusive. The Reporting Person hereby underta…

  3. F3

    The option is fully vested.

Original filing · 0001628280-26-058648
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ARQT